Jay Venkatesan's Net Worth
Estimate Recalculated Jan 2, 2025 09:07PM EST
Who is Jay Venkatesan
Jay Venkatesan has an estimated net worth of $6.62 Million. This is based on reported shares across multiple companies, which include Oncothyreon Inc., Targanta Therapeutics Corp., ALPINE IMMUNE SCIENCES, INC., Lion Biotechnologies, Inc., INSMED Inc, Max-1 Acquisition Corp, Elicio Therapeutics, Inc., and ACCESS PHARMACEUTICALS INC.
SEC CIK
Jay Venkatesan's CIK is 0001413350
Past Insider Trading and Trends
2021 was Jay Venkatesan's most active year for acquiring shares with 15 total transactions. Jay Venkatesan's most active month to acquire stocks was the month of November. 2021 was Jay Venkatesan's most active year for disposing of shares, totalling 10 transactions. Jay Venkatesan's most active month to dispose stocks was the month of January. 2021 saw Jay Venkatesan paying a total of $5,170,608.27 for 1,400,969 shares, this is the most they've acquired in one year. In 2021 Jay Venkatesan cashed out on 1,041,996 shares for a total of $6,171,353.98, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
